Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm

N.D. Oryshchyn, Yu.A. Ivaniv, Yu.H. Kyjak, S.S. Pavlyk, V.S. Moroz, D.I. Besh, I.M. Bigun

References

1. 1. Kyiak SO, Barnett OY, Kovalyshyn VI, Kyiak GYu. Correlation between clinical and cellular cardiology. Lviv, 2012. 160 p. (in Ukr.).
   2. Akutsu Y, Shinozuka A, Huang TY, et al. Hypertrophic cardiomyopathy with apical left ventricular aneurysm. Jpn Circ J. 1998;62:127-131.
   3. Duncan K, Shah A, Chaudhry F, et al. Hypertrophic cardiomyopathy with massive midventricular hypertrophy, midventricular obstruction and an akinetic apical chamber. Anadolu Kardiyol Derg. 2006;6:279-282.
   4. Efthimiadis GK, Pagourelias ED, Parcharidou DG, et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction. Circ J. 2013;77:2366-2374.
   5. Gao X-J, Kang L-M, Zhang J, Dou K-F. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review. Chin Med J. 2011;124:1754-1757.
   6. Ho CY, López B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010;363(6):552-563.
   7. Holloway CJ, Betts TR, Neubauer S, Myerson SG. Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia. J Am Coll Cardiol. 2010;56:1961.
   8. Krams R, Kofflard MJ, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation. 1998;97:230-233.
   9. Maron M, Finley JJ, Bos JM. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118:1541-1549.
   10. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012;14:13.
   11. Matsubara K, Nakamura T, Kuribayashi T, et al. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;42:288-295.
   12. Minami Y, Kajamoto K, Terajima Y, et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011;57:2346-2355.
   13. Park J-S, Cho IH, Shin DG, et al. Hypertrophic cardiomyopathy complicated by left ventricular apical necrosis and aneurysm in a young man: FDG-PET findings. Korean J Intern Med. 2007;22:28-31.
   14. Petersen SE, Jerosch-Herold M, Hudsmith LE. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation. 2007;115:2418-2425.
   15. Sanghvi NK, Tracy CM. Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm. Pacing Clin Electrophysiol. 2007;30:799-803.
   16. Sato Y, Matsumoto N, Matsuo S, et al. Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm: evaluation of possible causes of aneurysm formation. Yonsei Med. J. 2007;48:879-882.
   17. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol. 1998;31:1089-1096.
   18. Tse HF, Ho HH. Sudden cardiac death caused by hypertrophic cardiomyopathy associated with midventricular obstruction and apical aneurysm. Heart. 2003;89:178.
   19. Xiao Y, Wang L, Yang Y, et al. Clinical profile and prognosis of left ventricular apical aneurysm in hypertrophic cardiomyopathy. Am J Med Sciences. 2016;351:101-110.